Lybrel (levonorgestrel and ethinyl estradiol)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
June 2016
WARNINGS
Thromboembolic Disorders and Other Vascular Problems
Venous Thrombosis and Thromboembolism (addition of the...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts